ReadeRx Therapeutics

RNA-based Cancer Therapeutics

Active Pre-Funding Startup Tel Aviv-Yafo Founded 2023-01

Website ↗

ReadeRx is developing small molecule inhibitors targeting the RNA binding protein IGF2BP1 as a novel treatment for cancer. IGF2BP1 is an oncofetal RNA binding protein expressed in many types of cancers. it regulates RNA function at many levels, including intracellular RNA localization, RNA stability, and translational control. IGFB2P1 is widely expressed in…